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Background: Hypertension in pregnancy is common, with significant maternal/ perinatal morbidity and mortality. Drugs that block the renin-
angiotensin-aldosterone system are contra-indicated because they can harm the fetus. However, young women are increasingly being prescribed 
these drugs.
Methods: We reviewed the use of angiotensin converting enzyme inhibitors (ACE-I) or angiotensin receptor blockers (ARB) in pregnant women 
attending our antenatal hypertension clinic. Since 1990 we have managed 86 pregnancies (82 women) conceived whilst taking an ACE-I (n=66) or 
an ARB (n=20) or had been prescribed these agents in early pregnancy. In all cases, we recommended immediate cessation at the first visit and 
prescribed safer alternatives as necessary.
Results: The mean (SD) age of the women was 35 (5) years; 39 South Asian, 31 African, 15 European and one Sino-Asian; ACE-I/ARBs were 
consumed until median weeks gestation (IQR 0 to 28 weeks); 21 women had diabetes mellitus; 6 had gestational diabetes and 4 had intrinsic renal 
disease. Table 1 describes the adverse outcomes noted. The median birth weight was 2.38 kg (range 0.32 to 4.20); birth weights < 25th centile were 
seen in 33 babies (47%); the median Ponderal Index was 23.1 kg/m3 (range 15.1 to 35.1 kg/m3).
Conclusions: Our survey in high-risk pregnancies shows a high incidence of adverse pregnancy outcomes in women on ACE-I/ARBs at conception. 
Hence they should not be used in women of child-bearing potential.
Table 1: Pregnancy outcomes 
Early miscarriages 4
Late intra-uterine/ early neonatal deaths 5
Termination of pregnancy due to fears of teratogenecity 1
Oligohydramnios 3
Developmental birth defects [trisomy 13; craniosynostosis; ventricular septal defect; sensori-neural deafness; 
microcephaly; hypospadias; hypotonia]
7
